CompletedNot Applicable

Maternal- Fetal Infection

France2,569 participantsStarted 2018-08-28

Plain-language summary

The purpose of the protocol is to validate a novel point of care multiplex system to detect and characterize microorganisms responsible for neonatal sepsis, as well as biomarkers of infection, from a simple vaginal sample, in order to improve the prevention of perinatal bacterial infections.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pregnant woman, * Gestational age over 22 SA, * Patient agreeing to sign informed consent, * Patient aged at least 18 years old, * Patient with health insurance, * Singleton, twin or multiple pregnancy. Exclusion Criteria: * Fetal death or non-viable fetus, * maternal age under 18, * Patient unable to express her consent, * Patient under guardianship.

What they're measuring

Presence of Streptococcus B

Timeframe: Day 0

Presence of Streptococcus B

Timeframe: until 20 weeks

Trial details

NCT IDNCT03371056

SponsorAssistance Publique - Hôpitaux de Paris

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-08-30

View on ClinicalTrials.gov More Neonatal Infection trials